Stay updated with breaking news from Andreas Reiter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jul 04, 2023 Balzers, Liechtenstein, July 4, 2023 - When machining hardened steels, stainless steels or high-temperature alloys, tools are exposed to high thermal loads....
-- New analyses showing AYVAKIT® (avapritinib) significantly improved overall survival in advanced SM, when indirectly compared to real-world data for prior...
Ayvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis - News - PharmaTimes
Blueprint Medicines' AYVAKYT® (avapritinib) Receives Positive CHMP Opinion for the Treatment of Adults with Advanced Systemic Mastocytosis - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...